-
Giulia Galli,
Aldo Pinchera,
Paolo Piaggi,
Paola Fierabracci,
Monica Giannetti,
Giorgia Querci,
Giovanni Scartabelli,
Luca Manetti,
Giovanni Ceccarini, Silvia Martinelli,
Claudio Di Salvo,
Marco Anselmino,
Fausto Bogazzi,
Alberto Landi,
Paolo Vitti,
Margherita Maffei,
Ferruccio Santini
[show abstract]
[hide abstract]
ABSTRACT: Obesity is associated with abnormalities of the growth hormone/insulin-like growth factor-1 (GH/IGF-1) axis. The role of serum IGF-1 measurement for recognition of hypothalamic-pituitary diseases in obesity is still a matter of debate.
This study evaluated the serum levels of IGF-1 in a population of severely obese women before and after long-term weight loss obtained by laparoscopic adjustable gastric banding (LAGB). Eighty obese women with body mass index (BMI) of more than 34 kg/m(2) and 80 unrelated age-matched lean controls were enrolled. IGF-1 serum levels were measured together with BMI, liver volume, and intra-abdominal fat thickness assessed by ultrasound. Evaluation was repeated 2 years after LAGB.
Our results showed that mean IGF-1 levels in obese subjects before LAGB were significantly lower (p < 0.001) than that observed in age-matched controls. Age and BMI were independent predictors of serum IGF-1 values, overall accounting for 39 % of IGF-1 variability. The mean IGF-1 concentration significantly increased 2 years after LAGB. BMI reduction was independently associated with IGF-1 increase (r = -0.29, p < 0.001). For each point of BMI reduction, the mean increase of serum IGF-1 was 4.39 ng/mL.
(1) Severely obese women have low IGF-1 serum levels with respect to normal weight age-matched controls; (2) the extent of IGF-1 deficiency is proportional to increased BMI; (3) after LAGB a spontaneous raise of serum IGF-1 occurs, proportional to the extent of weight reduction; and (4) serum IGF-1 in severely obese subjects may have a limited value for detection of hypothalamic-pituitary diseases.
Obesity Surgery 05/2012; 22(8):1276-80. · 3.29 Impact Factor
-
Caterina Pelosini, Silvia Martinelli,
Brunella Bagattini,
Enrico Pucci,
Paola Fierabracci,
Giovanna Scartabelli,
Guido Salvetti,
Paolo Vitti,
Margherita Maffei,
Aldo Pinchera,
Ferruccio Santini
[show abstract]
[hide abstract]
ABSTRACT: A 54-year-old Italian female patient was admitted to our Department with the diagnosis of type 2 diabetes poorly controlled with insulin therapy. The patient was born by consanguineous parents (first degree cousins); she had acromegaloid features, diffuse lipoatrophy and muscular pseudo-hypertrophy since childhood. To confirm the clinical hypothesis of congenital generalized lipodystrophy (CGL) or Berardinelli-Seip syndrome, the sequences of AGPAT2 (encoding for 1-acyl-sn-glycerol-3-phosphate acyltransferase beta) and BSCL2 (encoding for seipin) candidate genes were analyzed. DNA analysis showed the presence of a homozygous mutation in exon 3 of the AGPAT2 gene (P112L). This is the first description of a Caucasian subject with CGL who carries the pathologic allelic variant P112L of the AGPAT2 gene.
Acta Diabetologica 07/2011; 48(3):243-6. · 2.78 Impact Factor
-
Paola Fierabracci,
Aldo Pinchera, Silvia Martinelli,
Giovanna Scartabelli,
Guido Salvetti,
Monica Giannetti,
Andrea Pucci,
Giulia Galli,
Ilaria Ricco,
Giorgia Querci,
Teresa Rago,
Claudio Di Salvo,
Marco Anselmino,
Paolo Vitti,
Ferruccio Santini
[show abstract]
[hide abstract]
ABSTRACT: Bariatric surgery allows stable body weight reduction in morbidly obese patients. In presurgical evaluation, obesity-related co-morbidities must be considered, and a multidisciplinary approach is recommended. Precise guidelines concerning the endocrinological evaluation to be performed before surgery are not available. The aim of this study was to evaluate the prevalence of common endocrine diseases in a series of obese patients scheduled for bariatric surgery.
We examined 783 consecutive obese subjects (174 males and 609 females) aged 18-65 years, who turned to the obesity centre of our department from January 2004 to December 2007 for evaluation before bariatric surgery. Thyroid, parathyroid, adrenal and pituitary function was evaluated by measurement of serum hormones. Specific imaging or supplementary diagnostic tests were performed when indicated.
The overall prevalence of endocrine diseases, not including type 2 diabetes mellitus, was 47.4%. The prevalence of primary hypothyroidism was 18.1%; pituitary disease was observed in 1.9%, Cushing syndrome in 0.8%, while other diseases were found in less than 1% of subjects. Remarkably, the prevalence of newly diagnosed endocrine disorders was 16.3%.
A careful endocrinological evaluation of obese subjects scheduled for bariatric surgery may reveal undiagnosed dysfunctions that require specific therapy and/or contraindicate the surgical treatment in a substantial proportion of patients. These results may help to define the extent of the endocrinological screening to be performed in obese patients undergoing bariatric surgery.
Obesity Surgery 10/2010; 21(1):54-60. · 3.29 Impact Factor
